Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Merigan

Showing results (41-50 of 366) with videos related to

Pageof 37
Sort By:
Virology|February 1, 1974
Interferon production by individual cellsR Rodgers, T C Merigan
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1970
Failure of an interferon inducer to inhibit multiplication of Mycobacterium lepraeL Levy, T C Merigan
The Journal of Infectious Diseases|February 1, 1971
Bis-DEAE-fluorenone: mechanism of antiviral protection and stimulation of interferon production in the mouseE De Clercq, T C Merigan
AIDS (London, England)|July 1, 1992
Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytesS K Kundu, T C Merigan
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1970
Simultaneous viral and non-viral interferon production in human cell culturesG H Bausek, T C Merigan
International Journal of Radiation Oncology, Biology, Physics|January 1, 1976
Virus infectionsD A Stevens, T C Merigan
Rational Drug Therapy|September 1, 1971
Approaches to the control of viral infections in manD A Stevens, T C Merigan
Annals of Internal Medicine|December 1, 1979
Prolonged herpes-zoster infection associated with immunosuppressive therapyJ G Gallagher, T C Merigan
Annual Review of Pharmacology|January 1, 1975
Enhancement of host defense mechanisms by pharmacological agentsG W Jordan, T C Merigan
AIDS Research and Human Retroviruses|November 1, 1993
Continuous presence of CD4-PE40 is required for antiviral activity against single-passage HIV isolates and infected peripheral blood mononuclear cellsM A Winters, T C Merigan
Pageof 37

Showing results (41-50 of 366) with videos related to

Sort By:
Pageof 37
Virology|February 1, 1974
Interferon production by individual cellsR Rodgers, T C Merigan
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1970
Failure of an interferon inducer to inhibit multiplication of Mycobacterium lepraeL Levy, T C Merigan
The Journal of Infectious Diseases|February 1, 1971
Bis-DEAE-fluorenone: mechanism of antiviral protection and stimulation of interferon production in the mouseE De Clercq, T C Merigan
AIDS (London, England)|July 1, 1992
Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytesS K Kundu, T C Merigan
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1970
Simultaneous viral and non-viral interferon production in human cell culturesG H Bausek, T C Merigan
International Journal of Radiation Oncology, Biology, Physics|January 1, 1976
Virus infectionsD A Stevens, T C Merigan
Rational Drug Therapy|September 1, 1971
Approaches to the control of viral infections in manD A Stevens, T C Merigan
Annals of Internal Medicine|December 1, 1979
Prolonged herpes-zoster infection associated with immunosuppressive therapyJ G Gallagher, T C Merigan
Annual Review of Pharmacology|January 1, 1975
Enhancement of host defense mechanisms by pharmacological agentsG W Jordan, T C Merigan
AIDS Research and Human Retroviruses|November 1, 1993
Continuous presence of CD4-PE40 is required for antiviral activity against single-passage HIV isolates and infected peripheral blood mononuclear cellsM A Winters, T C Merigan
Pageof 37